IOPs are interconnected, forming a dense and dynamic network. Our IOPs Network Monitoring service maps this ecosystem, analyzes its evolution over time, and identifies the most active illicit pharmacies in it.
Indicators for 2023:
active IOPs
targeted U.S. customers monthly.
IOPs had an average of
links with other IOPs.
IOPs sell thousands of distinct medicines in varying amounts. Our IOPs Sales Monitoring service estimates the volume traded for each medicine and the economic loss this represents for the legitimate pharmaceutical industry.
Indicators for 2023:
U.S. purchases from IOPs
totaled
IOP sales represented a loss of
to the U.S. pharmaceutical industry.
The consumption of medicines purchased from IOPs poses serious healthcare risks. Our IOPs Health Impact Monitoring service estimates the adverse health consequences of IOPs sales and their cost to the healthcare system.
Indicators for 2023:
IOP sales generated
excess adverse drug reactions in the U.S.
IOP sales led to an additional
in healthcare costs in the U.S.
A member of our team will contact you shortly.
Madrid (Spain)
info@translucentdatalab.com